Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

What you need to know about the coronavirus right now

09/27/2021 | 01:17am EDT

Sept 28 (Reuters) - Here's what you need to know about the coronavirus right now:

Japan to lift emergency curbs

Japan will lift a state of emergency in all regions on Thursday for the first time in nearly six months, as the number of new cases and deaths falls and the strain on the medical system eases, Prime Minister Yoshihide Suga said.

Daily cases have fallen nationwide from more than 25,000 last month to 1,128 on Monday, but the opening will be gradual with some curbs on restaurants and large-scale events staying in place for about a month.

The government will introduce a certification system whereby only approved restaurants can stay open until 9 p.m and a ban on serving alcohol will be lifted everywhere unless local governors object.

Russia reports record daily deaths

Russia on Tuesday reported 852 deaths from COVID-19 in the past 24 hours, above the previous all-time high recorded last week amid a spike in cases.

Authorities reported 21,559 new cases in the past 24 hours, slightly down from 22,236 on Monday.

New York hospitals fire, suspend staff who refuse vaccine

New York hospitals on Monday began firing or suspending healthcare workers for defying a state order to get the COVID-19 vaccine, and resulting staff shortages prompted some hospitals to postpone elective surgeries or curtail services.

New York City Mayor Bill de Blasio told a news conference the city's hospitals were not yet seeing a major impact from the mandate, adding he worried about other areas of the state where vaccination rates are lower.

A spokeswoman for Catholic Health, one of the largest healthcare providers in Western New York, said it had reached full compliance, counting staff members who had been vaccinated, those with exemptions and some who had been suspended without pay.

Sydney's unvaccinated warned of social isolation

Sydney residents who are not vaccinated against COVID-19 risk being barred from various social activities even when they are freed from stay-at-home orders in December, New South Wales state Premier Gladys Berejiklian warned on Tuesday.

Under a roadmap to exit lockdown in Australia's biggest city, unvaccinated people are already subject to delays in freedoms that will be gradually granted to inoculated residents between Oct. 11 and Dec. 1.

Sanofi ditches mRNA vaccine

Sanofi is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominance achieved by BioNTech-Pfizer and Moderna in using the technology to fight the pandemic, the company said on Tuesday.

The move highlights the challenges of competing in particular with pioneer BioNTech, which rose from obscurity through its alliance with pharma major Pfizer last year. They have delivered close to 1.5 billion doses so far to become the Western world's largest COVID-19 vaccine maker.

French healthcare group Sanofi will instead focus on efforts with British partner GlaxoSmithKline to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach, where mass trials are ongoing.

Pfizer submits data for vaccine in younger children

Pfizer and BioNTech on Tuesday submitted initial trial data for their COVID-19 vaccine in children aged 5 to 11 and said they would make a formal request with U.S. regulators for emergency use in the coming weeks.

India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enroll kids aged 7-11 years for its trial of U.S. drugmaker Novavax's vaccine.

(Open https://tmsnrt.rs/2FkV6wq in a web browser to see Reuters global coronavirus tracker) (Compiled by Linda Noakes; Editing by Alex Richardson)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
GLAXOSMITHKLINE PLC -0.30% 1383 Delayed Quote.3.37%
MODERNA, INC. -6.49% 382.2177 Delayed Quote.291.35%
NOVAVAX, INC. -12.26% 203.01 Delayed Quote.107.19%
SANOFI -0.50% 81.71 Real-time Quote.4.35%
All news about MODERNA, INC.
12:06pMODERNA : Covid-19 - Nigeria Must Do More to Achieve Herd Immunity Against Virus - Officia..
AQ
08:19aMODERNA : to Present at Chardan's Virtual 5th Annual Genetic Medicines Conference
BU
08:13aSanofi ditches mRNA COVID-19 vaccine after rivals' success
RE
08:11aMODERNA : EMA evaluating data on booster dose of COVID-19 vaccine Spikevax
AQ
07:03aMODERNA : Pfizer submits data for COVID-19 vaccine use in younger kids
RE
06:44aEUROPEAN MIDDAY BRIEFING : Stocks Fall as Traders Eye Inflation
DJ
06:11aNORTH AMERICAN MORNING BRIEFING : Stock Futures Slip as Bond Yields Hit Three-Month High
DJ
05:06aASTRAZENECA : Govt - 4.7 Million Eligible Nigerians Have Received First Dose of Covid-19 V..
AQ
03:06aASTRAZENECA : Covid-19 - Govt Says 1.8m Nigerians Fully Vaccinated
AQ
02:31aGolding entra nel mercato a impatto con un fondo globale di private equity da 300 milio..
DJ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 333 M - -
Net income 2021 12 514 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 13,8x
Yield 2021 -
Capitalization 165 B 165 B -
EV / Sales 2021 7,48x
EV / Sales 2022 6,77x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 408,84 $
Average target price 307,77 $
Spread / Average Target -24,7%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.291.35%165 027
LONZA GROUP AG26.86%57 923
IQVIA HOLDINGS INC.38.49%47 547
CELLTRION, INC.-25.49%31 003
SEAGEN INC.-7.21%29 566
PHARMARON BEIJING CO., LTD.78.56%25 147